Clinical Trials on Immune Cells (Mucosal and Systemic) in France

Total 18953 results

University Hospital, Strasbourg, France

Unknown

Visual Perception in Preterm Infants (PREMAVISION)

Pediatrics

France
Central Hospital, Nancy, France

Completed

Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations (BDD TEP FDG)

Lymphoma

France
Objectif Recherche Vaccins SIDA

Completed

Exploration of HIV Reservoirs (MUCOVIR)

HIV-1 Infection

France
Centre Hospitalier Universitaire de Nice

Recruiting

Combined Analysis of Inflammatory Biomarkers for CNS Autoimmune Diseases Diagnostic (CyBIRD)

Central Nervous System Diseases

France
Poitiers University Hospital
Sanofi; Celgene; Amgen; Intergroupe Francophone du Myelome

Active, not recruiting

Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma in Relapse | Multiple Myeloma, Refractory

France
Laboratoire français de Fractionnement et de Biotechnologies

Completed

LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

France
Hospices Civils de Lyon

Recruiting

Psycho-social Impact of Anti-NMDAR Encephalitis (SAPIENCE)

NMDAR Antibody-associated Auto-immune Encephalitis

France
National Cancer Institute (NCI)

Active, not recruiting

A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma

Clinical Stage III Cutaneous Melanoma AJCC v8 | Mucosal Melanoma | Acral Lentiginous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8

United States
Intergroupe Francophone du Myelome

Completed

Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies (MOZOBIL)

Multiple Myeloma | Blood Stem Cell Transplant Failure

France
University Hospital, Montpellier

Completed

Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome (MR-ICANS)

Lymphoma, B-Cell | Neurotoxicity

France
University Hospital, Clermont-Ferrand
Laboratoires Takeda

Unknown

Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple (SENSIB)

Multiple Myeloma | Adult | Bortezomib Regimen

France
Assistance Publique - Hôpitaux de Paris

Completed

Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment (IDeATIon)

Glioma | Non Small Cell Lung Cancer | Non Hodgkin Lymphoma

France
Hospices Civils de Lyon

Unknown

Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS) (IMMUNOSEPSIS)

Immunology of Septic Shock

France
University Hospital, Lille

Completed

Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients (B-MS)

Multiple Sclerosis | Systemic Sclerosis

France
Cureety

Completed

Sensitivity and Specificity of the Clinical Classifications Generated by the Cureety Digital Telemonitoring Tool (POSITEA-VA)

Neoplasms

France
UCB Pharma

Completed

Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.

Allergy

France
Association de Recherche en Virologie et Dermatologie
ViiV Healthcare

Completed

Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy (MUTARESERVOIR)

HIV-1-infection

France
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France

Active, not recruiting

Reducing Antiretroviral Treatments (ALTAR)

HIV-1-infection

France
Tourcoing Hospital

Completed

Influenza Vaccination in Patients Living With HIV in the Northern Region (VACCIGRIPPE)

HIV

France
University Hospital, Montpellier

Completed

Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice (CHOICE)

Allergen Immunotherapy

France
InnaVirVax

Completed

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

HIV-1 Infection

France
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA) (CLINDOS)

Osteoarticular Infection

France
Central Hospital, Nancy, France
University Hospital, Rouen; Centre Hospitalier Universitaire Dijon; University... and other collaborators

Completed

A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis. (FLARE)

Arthritis, Rheumatoid

France
Celgene
Celgene Corporation

Completed

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Cutaneous T-cell Lymphoma

United States, France, Germany, Poland, Russian Federation, United Kingdom
Hospices Civils de Lyon

Unknown

Diffusion Imaging in Acute Auto-immune Encephalitis

Auto-immune Encephalitis

France
Janssen Research & Development, LLC
Pharmacyclics LLC.

Completed

A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma

CD20-positive B-cell Non-Hodgkin Lymphoma

United States, France
Sanofi

Completed

SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma

Lymphoma | Non-Hodgkin

France
Institut Paoli-Calmettes

Completed

Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma (PLERIXAFOR)

Multiple Myeloma

France
AbbVie

Completed

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia

Leukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)

United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
The Lymphoma Academic Research Organisation
Pfizer; Takeda; Hôpital Necker-Enfants Malades; Fondation ARC

Completed

Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma

Anaplastic Large Cell Lymphoma, ALK-Positive

France
Assistance Publique - Hôpitaux de Paris

Completed

SARCOTHAL. Thalidomide in Skin Sarcoidosis

Sarcoidosis

France
Centre Hospitalier Universitaire de Nīmes

Withdrawn

Exploratory Study on the Role of the Digestive Microbiota in Adults Living With HIV-1 (MICRACTIVIH)

HIV

France
University Hospital, Clermont-Ferrand

Completed

Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders. (PREVIB)

Multiple Myeloma | Chemotherapy Induced Peripheral Neuropathy

France
Assistance Publique - Hôpitaux de Paris

Recruiting

A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults (GRAAPH2014)

Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia

France
David Garcia Cinca
Dr. Josep Mallolas

Unknown

Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study (DORAVIPEP)

Hiv

Spain, France
Institut Paoli-Calmettes
CHU de Reims

Unknown

Autoimmune Cytopenia and BcR Inhibitors (CABRI)

Autoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia

France
University Hospital, Clermont-Ferrand

Unknown

Comparative Evaluation of the Effect on Blood Pressure of an Equivalent Content of Sodium in the Form of Bicarbonate of Sodium and in the Form of Sodium Chloride, on "Sensitive Sodium" Subjects (SODIVASC)

Healthy

France
Step Pharma, SAS

Recruiting

A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Lymphoma, B-Cell | Lymphoma, T-Cell

United States, France, United Kingdom
Centre Hospitalier Universitaire, Amiens
University Hospital, Rouen; University Hospital, Caen

Recruiting

Physical Activity for Myeloma Autograft Longitudinal Study (PAMAL)

Quality of Life | Physical Activity | Multiple Myeloma

France
Centre Antoine Lacassagne

Terminated

Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter (QASICC-EVA)

Malignant Mast Cell Tumors | Solid Organ Sites

France
Centre Hospitalier Universitaire Dijon

Completed

Eating Behaviour and Gustatory Sensitivity Before and After Liver Transplant in Cirrhotic Patients (GREFFE)

Liver Transplant | Eating Behaviour

France
University Hospital, Brest

Completed

Impact of Exposure to Cosmetics on Sensitive Skin (SENSICOS)

Sensitive Skin | Cosmetic Exposure

France
Assistance Publique - Hôpitaux de Paris

Completed

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT (ATG-CyGVHD)

Graft vs Host Disease

France
ALK-Abelló A/S

Completed

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet (MT-06)

House Dust Mite Allergy

France
University Hospital, Brest

Completed

Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica (TENOR-IMMUNO)

Polymyalgia Rheumatica

France
University Hospital, Strasbourg, France

Recruiting

Pediatric ANCA Associated-vasculitis (PediANCA)

ANCA-Associated Vasculitis

France
Janssen Research & Development, LLC

Completed

A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma

Lymphoma, T-Cell, Cutaneous

France, United Kingdom, Spain, Portugal, United States, Germany
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease (HORTIM)

Horton Disease

France
Institut de Myologie, France

Completed

Sensitivity and Reproducibility of 18F-fluorodeoxyglucose Positron Emission Tomography for Assessment of Respiratory Muscle Activity (ResPET)

Respiratory Muscle

France

Clinical Trials on Immune Cells (Mucosal and Systemic) in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations